tirzepatide launch date Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, (Zepbound). The device gives patients an additional, potentially more convenient option for taking the drug: They can what are the brands of

Table of Contents: Why Athletes Choose Spa Blue Orlando

Brown Adipose Tissue Mimicking Head and Neck Cancer on PET Scan in a Patient on GLP-1 Drug

This holistic approach tackles the root causes of weight gain, leading to lasting change

The Substance (2024), French director Coralie Fargeats sophomore feature, is perhaps the highest-profile post-Ozempic film4 to date, and, understandably, dredged up a lot of Discourse after its surprise runaway success at the box office this fall (as well as a baffling screenplay win at Cannes in May)

Ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD

Factors like additional patents on the drug and its injection devices, ongoing clinical research, and how aggressively manufacturers defend their exclusivity can all influence how long it takes before lower-cost versions become available